Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer.

JNCI cancer spectrum·2026
Same author

Immune checkpoints TIM-3 and Gal-9 are upregulated in male placentas with acute SARS-CoV-2 infection.

Journal of reproductive immunology·2025
Same author

The emerging role of human transmembrane RGD-based counter-receptors of integrins in health and disease.

Cellular & molecular biology letters·2025
Same author

Safety, Pharmacokinetics, and Pharmacodynamics of BI 1595043, a Selective Vanin Inhibitor, in Phase 1 Clinical Trials Involving Healthy Volunteers.

Clinical and translational science·2025
Same author

Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis.

ERJ open research·2025
Same author

Author Correction: Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.

Nature genetics·2025

Related Experiment Video

Updated: May 20, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

CD24 controls Src/STAT3 activity in human tumors.

Niko P Bretz1, Alexei V Salnikov, Claudia Perne

  • 1Tumor Immunology Programme, German Cancer Research Center, Heidelberg, Germany.

Cellular and Molecular Life Sciences : CMLS
|July 5, 2012
PubMed
Summary

CD24 protein, often overexpressed in cancers, drives tumor growth by regulating STAT3 and FAK pathways via Src. Targeting CD24 with antibodies may offer a new cancer therapy approach.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Related Experiment Videos

Last Updated: May 20, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • CD24 is a membrane protein overexpressed in various human carcinomas, linked to poor prognosis.
  • CD24's role in mediating cancer cell properties and tumor growth is not fully understood.

Purpose of the Study:

  • To investigate the functional consequences of CD24 modulation (knock-down and over-expression) in human cancer cell lines.
  • To elucidate the molecular mechanisms by which CD24 influences cancer cell behavior and signaling pathways.

Main Methods:

  • CD24 gene expression was modulated using knock-down and over-expression techniques in cancer cell lines.
  • Analysis of cell proliferation, adhesion, apoptosis, and gene expression.
  • Western blotting and reporter assays were used to assess STAT3, FAK, and Src phosphorylation and activity.
  • In vivo studies using human cancer xenografts in mice treated with anti-CD24 antibodies.

Main Results:

  • CD24 depletion reduced proliferation, adhesion, and enhanced apoptosis, altering STAT3 target gene expression.
  • Loss of CD24 decreased STAT3 and FAK phosphorylation, with reduced STAT3 activity linked to altered Src phosphorylation.
  • CD24 over-expression increased Src phosphorylation and STAT3-dependent gene expression.
  • Anti-CD24 antibody treatment reduced tumor growth in vivo, affecting Src phosphorylation and STAT3 target gene expression.

Conclusions:

  • CD24 plays a significant role in regulating cancer cell proliferation, adhesion, and apoptosis.
  • CD24 modulates STAT3 and FAK signaling pathways, with Src acting as a key mediator.
  • Targeting CD24 with antibodies presents a potential novel therapeutic strategy for cancer treatment.